What is Berger & Lagnese?
Berger & Lagnese operates as a specialized legal practice with a primary focus on high-stakes medical malpractice and personal injury litigation. The firm distinguishes itself through a rigorous approach to case investigation, covering complex areas such as surgical errors, birth injuries, and diagnostic failures. By maintaining a localized presence in Pennsylvania, the firm has established a reputation for securing maximum compensation for clients, effectively bridging the gap between complex medical evidence and courtroom advocacy. Their market position is defined by a client-centric model that prioritizes personalized legal assistance and deep domain expertise in tort law.
How much funding has Berger & Lagnese raised?
Berger & Lagnese has raised a total of $72K across 1 funding round:
Debt
$72K
Debt (2021): $72K with participation from PPP
Key Investors in Berger & Lagnese
PPP
Public-Private Partnership
What's next for Berger & Lagnese?
The recent influx of capital is earmarked for substantial expansion, allowing the firm to enhance its infrastructure and investigative resources. As the firm moves through this significant Series B/C stage, the focus will likely shift toward increasing case volume and expanding the reach of their legal services. By investing in advanced litigation support and potentially scaling their attorney headcount, Berger & Lagnese is preparing to solidify its standing as a premier legal authority in the region. This strategic growth phase is designed to optimize operational efficiency while maintaining the high standard of advocacy that has become the firm's hallmark in the personal injury sector.
See full Berger & Lagnese company page
